(R)-2-amino-3-(1H-imidazol-4-yl)-N-(naphthalen-1-ylmethyl)propanamide

ID: ALA5076603

PubChem CID: 146440139

Max Phase: Preclinical

Molecular Formula: C17H18N4O

Molecular Weight: 294.36

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  N[C@H](Cc1c[nH]cn1)C(=O)NCc1cccc2ccccc12

Standard InChI:  InChI=1S/C17H18N4O/c18-16(8-14-10-19-11-21-14)17(22)20-9-13-6-3-5-12-4-1-2-7-15(12)13/h1-7,10-11,16H,8-9,18H2,(H,19,21)(H,20,22)/t16-/m1/s1

Standard InChI Key:  UGYGRDVZHGAERG-MRXNPFEDSA-N

Molfile:  

 
     RDKit          2D

 22 24  0  0  0  0  0  0  0  0999 V2000
    3.8641    0.2094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1493   -0.2025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1493   -1.0269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4400   -1.4382    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7244   -1.0305    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7244   -0.2030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4382    0.2088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4382    1.0278    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1514    1.4382    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8641    1.0304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0108    0.2090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2972   -0.2030    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4172    0.2095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4172    1.0345    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1315   -0.2028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8456    0.2093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5597   -0.2028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3125    0.1323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8641   -0.4801    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4520   -1.1938    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6458   -1.0225    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1315   -1.0273    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  2  0
  4  3  1  0
  5  4  2  0
  6  5  1  0
  7  6  2  0
  2  7  1  0
  7  8  1  0
  9  8  2  0
 10  9  1  0
  1 10  2  0
 11  6  1  0
 12 11  1  0
 13 12  1  0
 13 14  2  0
 15 13  1  0
 15 16  1  0
 16 17  1  0
 18 17  2  0
 19 18  1  0
 20 19  1  0
 21 20  2  0
 21 17  1  0
 15 22  1  6
M  END

Alternative Forms

  1. Parent:

    ALA5076603

    ---

Associated Targets(non-human)

Nln Neurolysin, mitochondrial (179 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 294.36Molecular Weight (Monoisotopic): 294.1481AlogP: 1.75#Rotatable Bonds: 5
Polar Surface Area: 83.80Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 13.08CX Basic pKa: 7.84CX LogP: 1.12CX LogD: 0.54
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.67Np Likeness Score: -0.63

References

1.  (2020)  Enhancers of neurolysin activity, 
2. Rahman MS, Kumari S, Esfahani SH, Nozohouri S, Jayaraman S, Kinarivala N, Kocot J, Baez A, Farris D, Abbruscato TJ, Karamyan VT, Trippier PC..  (2021)  Discovery of First-in-Class Peptidomimetic Neurolysin Activators Possessing Enhanced Brain Penetration and Stability.,  64  (17.0): [PMID:34436882] [10.1021/acs.jmedchem.1c00759]